Dr. Tarek Ezzeddine, MD

Dr. Ezzeddine practices at Kindred Hospital Rancho in Rancho Cucamonga, California, part of ScionHealth.

Dr. Ezzeddine's NPI, 1740471879, was assigned on August 5, 2007. Dr. Ezzeddine graduated from University of Tripoli School of Medicine in 1999. Dr. Ezzeddine holds California license C133690.

Dr. Ezzeddine's primary practice is Kindred Hospital Rancho, at 10841 White Oak Avenue, Rancho Cucamonga, CA 91730 in San Bernardino County. The practice phone is (909) 581-6400.

Dr. Ezzeddine's primary practice is Kindred Hospital Rancho in Rancho Cucamonga, California, part of ScionHealth. The medical group on file is Cornerstone Specialty Hospitals Tucson. Dmand AI also links Dr. Ezzeddine to 8 more medical groups, 5 home health agencies, 3 group practices and clinics, 3 hospices and 2 physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ezzeddine practices, 14 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ezzeddine's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Ezzeddine's licenses on file in 2 states: California and Michigan.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, alzheimer's disease, anxiety, asthma, atrial fibrillation and flutter and bronchitis among the conditions Dr. Ezzeddine treats.

CMS data shows 122 Medicare services from Dr. Ezzeddine across 4 procedure codes in 2024, for 82 Medicare patients. Medicare paid $9,005 for them.

CMS counts 82 Medicare patients who saw Dr. Ezzeddine in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ezzeddine's median patient age at 48, with 57% women.

In 2024, Dr. Ezzeddine wrote 1,835 Medicare Part D claims for 303 patients. 87% of them were for generic drugs. CMS names the drug for 1,266 of them, across 49 drugs with 11 or more claims each, at $43,281 in total drug cost. In 2023, CMS named 1,114 claims across 48 drugs.

Dr. Ezzeddine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ezzeddine as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Ezzeddine to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Asthma and Respiratory Hypersensitivity. Open Payments lists research payments to Dr. Ezzeddine that name 1 trial.

CMS Open Payments shows 30 general payments to Dr. Ezzeddine from 8 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 53% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,208. It also lists 9 research payments totaling $1,664 in 2023, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Ezzeddine, most recently CMS Stage 1 EHR in 2013.

Dr. Ezzeddine graduated from University of Tripoli School of Medicine in 1999.

Dr. Ezzeddine is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.